Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB

https://doi.org/10.1016/0002-9149(91)90307-7Get rights and content

Abstract

The diagnostic sensitivity and performance of immunoenzymometric measurements of creatine kinase (CK)-MB mass concentrations in the early diagnosis of acute myocardial infarction (AMI) were examined and compared with the sensitivities and performances of CK and CK-MB activity, in the context of simultaneous measurements of CK, CK-MB activity, and CK-MB mass concentrations in serially drawn blood samples obtained immediately from 36 patients with AMI and 126 patients with chest pain on admission to the emergency room of the department of internal medicine. In the 36 patients with AMI, who were all admitted no later than 4 hours after the onset of chest pain, pathologic increase occurred significantly earlier in CK-MB mass than in both CK and CK-MB activity, with a median difference of 1 hour each. In patients coming to the emergency room (51 with AMI, 51 with angina pectoris and 24 with chest pain not related to coronary artery disease), CK-MB mass was the best diagnostic measurement for AMI of all markers tested (significantly higher efficiency, Youden index and likelihood ratio than both CK and CK-MB activity). Before initiating thrombolytic therapy, the sensitivity of CK-MB mass is significantly higher than CK-MB activity during the 0- to 6-hour period and significantly higher than CK activity during the 2- to 4-hour period after the onset of chest pain. Consequently, it is often possible to diagnose an AMI on the basis of increased CK-MB mass concentrations even at a time when CK and CK-MB activities are still within the reference interval.

References (26)

  • D Obzansky et al.

    Clinical evaluation of an immunoinhibition procedure for creatine kinase MB

    Clin Chem

    (1980)
  • ThH Lee et al.

    Serum enzyme assays in the diagnosis of acute myocardial infarction: recommendations based on a quantitative Analysis

    Ann Intern Med

    (1986)
  • DR Brandt et al.

    Quantifying the MB isoenzyme of creatine kinase with the Abbott “IMX” Immunoassay analyser

    Clin Chem

    (1990)
  • Cited by (118)

    • Multiplexed electrochemical immunosensor for label-free detection of cardiac markers using a carbon nanofiber array chip

      2016, Journal of Electroanalytical Chemistry
      Citation Excerpt :

      Rapid and accurate diagnosis of acute myocardial infarction (AMI) can help in devising appropriate and timely surgical procedures or cardiovascular disease therapy for heart patients, thereby avoiding life-threatening situations such as heart attack or heart failure [1–5].

    • The clinical significance of cardiac troponins in medical practice

      2011, Journal of the Saudi Heart Association
      Citation Excerpt :

      Troponin I can also be used for detecting re-infarction which is demonstrated by re-elevation of cTnI after it reaches the plateau (Apple and Murakami, 2005). Cardiac troponins are useful for the diagnosis of myocardial infarction and myocardial necrosis (Mair et al., 1991). They are more sensitive than CKMB for the detection of minor damage missed by conventional markers which are prognostically important (La Vecchia et al., 1996; Shyu et al., 1998; Harrington et al., 1995).

    • Biological markers of myocardial necrosis

      2003, Revista Espanola de Cardiologia
    View all citing articles on Scopus
    View full text